#USA #MedTech #Enlil #Shifamed #Campbell, California

Enlil's Development Traceability Platform: A Game Changer in MedTech

Enlil, Inc., a trailblazing company in the regulated products space, is witnessing a surge of support across the global MedTech innovation ecosystem. Since welcoming Nader Fathi as CEO in February, Enlil has become a vital player for original equipment manufacturers (OEMs) and contract manufacturers, expanding its impact significantly. With over 600 users around the world, Enlil is not just a platform but a revolution in how MedTech entities navigate the path from concept to commercialization.

The crux of Enlil’s offering lies in its innovative use of AI-driven intelligence. Central to its platform is a private large language model (LLM)-powered chatbot, Ask Lily. By incorporating secure and contextual AI, Enlil equips engineering, quality, and regulatory teams with instantaneous insights, enabling them to make informed decisions while safeguarding sensitive intellectual property and maintaining compliance.

Success Through Next-Gen Technology

Enlil’s framework addresses the shortcomings of conventional technologies that led to fragmented processes and isolated information. Its integrated development traceability approach provides end-to-end transparency, enhances secure cross-functional collaboration, and ensures rapid regulatory responsiveness from the brainstorming phase all the way to post-market evaluations.

The platform weaves together essential product development disciplines—such as Requirements Management, Quality Management Systems (QMS), Product Lifecycle Management (PLM), Manufacturing, Enterprise Resource Planning (ERP), Regulatory Compliance, and Post-Market Surveillance—into a cohesive digital narrative. This approach allows dispersed teams to collaborate in real time, fostering a culture of innovation.

As CEO Nader Fathi emphasized, “Today's MedTech ecosystem demands a solution that goes beyond outdated tools that are merely band-aids. It requires a meticulously crafted platform capable of addressing complex regulations, promoting collaboration, and expediting processes.” Enlil serves as a bridge between rapid product iteration and regulatory convergence, empowering teams to bring pioneering medical devices to market with confidence and swiftness.

Unique Features That Set Enlil Apart

• - Powered by Private AI: Enlil’s platform simplifies and accelerates various regulatory workflows, providing teams with AI-dependent insights and real-time change management features that keep them ahead in compliance.
• - Facilitation of Complex Development Relationships: The platform encourages smooth collaboration among innovation centers, contract manufacturers, and OEMs, no matter their geographical location.
• - Diverse Product Management: Enlil adeptly supports a range of MedTech hardware and software, including Software in a Medical Device (SiMD), Software as a Medical Device (SaMD), diagnostics, and more complex tech solutions.

With teams positioned around the globe, Enlil empowers OEMs and contract manufacturers to streamline documentation processes, increase visibility, and minimize regulatory barriers at every key development point. As Fathi pointed out, “MedTech organizations are increasingly recognizing that solutions from other sectors can fall short of meeting their distinctive regulatory challenges. Enlil was architected from the outset to speak the language of MedTech compliance, and that is why it has swiftly gained traction as the premier system for firms dedicated to fostering rapid yet responsible innovation.”

Enlil is strategically investing in talent acquisition and partnering with other entities to satisfy the progressively growing demand in the MedTech arena. Fueled by advanced AI capabilities and bolstered by the strength of the Shifamed innovation ecosystem, Enlil is poised to solidify its status as the foremost platform for the development of regulated medical products.

About Enlil

Enlil, Inc. provides a cloud-based development traceability platform that integrates compliance, quality, and engineering methods throughout the entire product lifecycle. Specifically designed for regulated industries, Enlil empowers MedTech innovators by offering digital traceability, instantaneous collaboration, and AI-fueled insights—thus expediting time to market while upholding stringent regulatory standards. For more details, visit enlil.com.

About Shifamed

Shifamed, located in Silicon Valley, is an innovative medical technology hub established by entrepreneur Amr Salahieh. Shifamed focuses on accelerating the market introduction of transformative health technologies by providing its portfolio companies with essential technical skills, operational proficiency, and a validated route to successful commercialization. Learn more at shifamed.com.